Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
The price of Health Catalyst Inc (NASDAQ: HCAT) closed at $5.47 in the last session, down -2.84% from day before closing price of $5.63. In other words, the price has decreased by -$2.84 from its previous closing price. On the day, 0.57 million shares were traded. HCAT stock price reached its highest trading level at $5.58 during the session, while it also had its lowest trading level at $5.3202.
Ratios:
We take a closer look at HCAT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.41 and its Current Ratio is at 1.41. In the meantime, Its Debt-to-Equity ratio is 1.03 whereas as Long-Term Debt/Eq ratio is at 0.37.
Evercore ISI Upgraded its In-line to Outperform on January 03, 2024, while the target price for the stock was maintained at $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jan 15 ’25 when Llewelyn Linda sold 6,442 shares for $5.80 per share. The transaction valued at 37,348 led to the insider holds 92,260 shares of the business.
LINDA LLEWELYN bought 6,442 shares of HCAT for $38,008 on Jan 15 ’25. On Jan 06 ’25, another insider, LeSueur Daniel, who serves as the Chief Operating Officer of the company, sold 5,209 shares for $7.51 each. As a result, the insider received 39,134 and left with 91,253 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 332836896 and an Enterprise Value of 309912704. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.10 while its Price-to-Book (P/B) ratio in mrq is 0.94. Its current Enterprise Value per Revenue stands at 1.026 whereas that against EBITDA is -9.66.
Stock Price History:
The Beta on a monthly basis for HCAT is 1.34, which has changed by -0.43360162 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, HCAT has reached a high of $10.31, while it has fallen to a 52-week low of $5.35. The 50-Day Moving Average of the stock is -23.13%, while the 200-Day Moving Average is calculated to be -23.41%.
Shares Statistics:
According to the various share statistics, HCAT traded on average about 643.98K shares per day over the past 3-months and 887120 shares per day over the past 10 days. A total of 60.85M shares are outstanding, with a floating share count of 58.54M. Insiders hold about 3.80% of the company’s shares, while institutions hold 86.51% stake in the company. Shares short for HCAT as of 1736899200 were 2562678 with a Short Ratio of 3.98, compared to 1734048000 on 2555695. Therefore, it implies a Short% of Shares Outstanding of 2562678 and a Short% of Float of 4.29.